The Effect of Magnet therapy on motor disorders in multiple sclerosis

Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system (CNS) the etiology of which is not fully understood and whose course is difficult to predict. The pathology and symptoms of the disease were first described by Jean-Martin Charcot in 1868. It is believed that a key role in the formation of demyelinating lesions may be played by autoimmune processes as well as environmental and genetic factors. The research into the pathophysiology of multiple sclerosis indicate that demyelinating changes affect the cerebral cortex and gray matter, including basal nuclei and cerebellar cortex.1 The process of inflammation, which is associated with the presence of pro-inflammatory cytokines and T-lymphocytes and macrophages, damages the blood - brain barrier, which is associated with neuronal malfunctioning and swelling, which in turn can result in a relapse of the disease.The rehabilitation program should take into consideration the phase of the disease, degree of disability and neurological deficits. The therapy at the time of remission is therefore based on the degree of impairment and the objectives of treatment.